Potential Therapeutic Effects of Chrysin and Apigenin in a Diethylnitrosamine-Induced Hepatocellular Carcinoma Rat Model

dc.contributor.authorTedik, Fatma
dc.contributor.authorIlhan, Nevin
dc.contributor.authorBodur, Solmaz
dc.contributor.authorBerk, Buket
dc.contributor.authorEroksuz, Hatice
dc.date.accessioned2026-09-08T07:14:00Z
dc.date.issued2026
dc.departmentFırat Üniveristesi
dc.description.abstractHepatocellular carcinoma (HCC) is an aggressive cancer with poor prognosis and high mortality rates. The increasing mortality associated with HCC highlights the urgent need for alternative therapeutic approaches. Natural products and their structural analogs have shown promise as novel treatment options. This study aimed to evaluate the potential therapeutic effects of the natural flavonoids apigenin and chrysin, administered individually and in combination, in an experimental HCC model. Forty-eight rats were divided into five groups: Control, DEN, DEN + Apigenin, DEN + Chrysin, and DEN + Combination. HCC was induced by intraperitoneal administration of diethylnitrosamine (DEN, 150 mg/kg), followed by oral 2-acetylaminofluorene (2-AAF, 20 mg/kg) according to a standardized protocol. Subsequently, Apigenin and chrysin were administered orally at 50 mg/kg for 8 weeks following tumor induction. At the end of the treatment, biochemical and histopathological analyses were performed on blood and liver tissue samples. Compared to controls, DEN-induced HCC was associated with activation of tumor-promoting signaling pathways, as evidenced by increased levels of survivin, annexin-V, smoothened, sonic hedgehog, jagged1, and notch1, alongside reduced caspase-3 expression. Histological examination revealed normal liver architecture in controls, while DEN-treated rats showed varying degrees of fibrosis (62.5% moderate to severe), inflammatory lesions, regenerative nodules, and 87.5% moderate to severe inflammation. Treatment groups displayed marked reductions in fibrosis and inflammation, with the most pronounced effects observed in DEN + Apigenin and combination groups. These findings suggest that apigenin, chrysin, and their combination may exert antitumor effects in experimental HCC, with apigenin demonstrating comparatively more pronounced activity based on biochemical and histopathological findings.
dc.identifier.doi10.1002/jbt.70998
dc.identifier.issn1095-6670
dc.identifier.issn1099-0461
dc.identifier.issue7
dc.identifier.pmid42346026
dc.identifier.scopus2-s2.0-105043160936
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1002/jbt.70998
dc.identifier.urihttps://hdl.handle.net/11508/65671
dc.identifier.volume40
dc.identifier.wosWOS:001801633700001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Biochemical and Molecular Toxicology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250903
dc.subject2-Acetylaminofluorene
dc.subjectApigenin
dc.subjectChrysin
dc.subjectDiethylnitrosamine
dc.subjectHepatocellular Carcinoma
dc.titlePotential Therapeutic Effects of Chrysin and Apigenin in a Diethylnitrosamine-Induced Hepatocellular Carcinoma Rat Model
dc.typeArticle

Dosyalar